09:00 – 09:30 Doors open and welcome coffee
09:30 – 09:45 Welcome words
09:45 – 10:15 Opening Keynote: From Immunological Insight to Societal Impact: How Co-Creation Transforms Breakthrough Science into Better Lives – Peter Ulrichts (Chief Scientific Officer at Argenx)
10:15 – 11:00 Patient spotlight: Can Belgium Lead the Immunology Revolution? – Els Van Gysel (Patient)
Belgium holds a unique position at the crossroads of antibody science, translational research and biopharmaceutical manufacturing. In this keynote, a patient voice is brought together with an industry perspective to illustrate how innovation translates into real-life impact. The session examines how Belgium can consolidate its leadership and remain a global hub for immunology-driven innovation while keeping patient needs at the centre of scientific progress.
11:00 – 11:30 Networking coffee break and booths & poster presentations
11:30 – 11:55 Keynote: Multispecific T Cell Engagers: The Next Generation of Cancer Immunotherapy – Ulrike Philippar (Vice President Oncology, Global Head of Discovery Hematological & Solid Malignancies at Johnson & Johnson Innovative Medicine)
11:55 – 12:30 Keynote: Richard Taylor (Director, CADD at UCB Pharma)
12:30 – 13:30 Networking lunch break and booths & poster presentations
Track 1 focuses on how immunology is translated into therapies that directly impact patients.
It explores clinical applications such as cancer immunotherapies, cancer vaccines and antibody–drug conjugates, with a strong emphasis on clinical outcomes, treatment strategies and real-world challenges in bringing these therapies to patients.
13:30 – 13:45 Case study 1
13:45 – 14:00 Case study 2
14:00 – 14:15 Case study 3
14:15 – 14:30 Case study 4
14:30 – 14:45 Case study 5
14:45 – 15:15 Panel Session
Track 2 centres on the scientific and technological foundations that enable next-generation immunotherapies.
It examines how antibodies are designed, engineered and optimised — from molecular architecture and functional enhancement to manufacturability — to create more precise, robust and scalable treatments.
13:30 – 13:45 Case study 1
13:45 – 14:00 Case study 2
14:00 – 14:15 Case study 3
14:15 – 14:30 Case study 4
14:30 – 14:45 Case study 5
14:45 – 15:15 Panel Session
15:15 – 16:00 Coffee break
16:00 – 16:30 Closing Keynote: Rewriting the Rules of the Immune System – TBA
This keynote explores how advances in immune biology are redefining medicine. From antibody engineering to cell-based approaches, the session highlights how the immune system is increasingly understood not just as a defense mechanism, but as a programmable platform for precision therapies.
16:30 – 17:15 Roundtable: Is Immunology Delivering on Its Promise? – TBA
This roundtable brings together experts from academia, biotech and pharma to openly discuss the current state of immunology. Moving beyond hype, the panel will debate what is working, what is not, and how to build cross regional collaborations to ensure innovation impact and resilient companies.
17:15 – 17:30 Closing Words
17:30 – 18:30 Reception
Cookies